| __timestamp | PTC Therapeutics, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 79838000 | 9216000000 |
| Thursday, January 1, 2015 | 121816000 | 8296000000 |
| Friday, January 1, 2016 | 117633000 | 10044000000 |
| Sunday, January 1, 2017 | 4577000 | 11560000000 |
| Monday, January 1, 2018 | 12670000 | 10558000000 |
| Tuesday, January 1, 2019 | 12135000 | 9351000000 |
| Wednesday, January 1, 2020 | 18942000 | 8933000000 |
| Friday, January 1, 2021 | 32328000 | 8284000000 |
| Saturday, January 1, 2022 | 44678000 | 7952000000 |
| Sunday, January 1, 2023 | 65486000 | 8200000000 |
| Monday, January 1, 2024 | 8480000000 |
Cracking the code
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. This analysis delves into the cost of revenue trends for Teva Pharmaceutical Industries Limited and PTC Therapeutics, Inc. from 2014 to 2023. Over this period, Teva's cost of revenue consistently dwarfed that of PTC, averaging around 9.2 billion annually, compared to PTC's 51 million. Notably, Teva's costs peaked in 2017 at approximately 11.6 billion, while PTC's highest was in 2015, reaching 122 million. Despite Teva's larger scale, both companies experienced a downward trend, with Teva's costs decreasing by about 13% and PTC's by 46% over the decade. This data highlights the contrasting scales and cost management strategies of these two industry players, offering insights into their operational efficiencies and market positioning.
AbbVie Inc. vs Teva Pharmaceutical Industries Limited: Efficiency in Cost of Revenue Explored
AstraZeneca PLC vs Teva Pharmaceutical Industries Limited: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Vertex Pharmaceuticals Incorporated and Teva Pharmaceutical Industries Limited's Expenses
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Intra-Cellular Therapies, Inc.'s Expenses
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs HUTCHMED (China) Limited
Cost of Revenue: Key Insights for Intra-Cellular Therapies, Inc. and PTC Therapeutics, Inc.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and PTC Therapeutics, Inc.'s Expenses
Jazz Pharmaceuticals plc vs PTC Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: PTC Therapeutics, Inc. and Supernus Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for PTC Therapeutics, Inc. and Mesoblast Limited
PTC Therapeutics, Inc. vs Xencor, Inc.: Efficiency in Cost of Revenue Explored
PTC Therapeutics, Inc. vs Evotec SE: Efficiency in Cost of Revenue Explored